BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Li Zhang
Sun Yat-sen University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Not, yet, recruiting - Hunan Cancer Hospital
Changsha, Hunan, China
Not, yet, recruiting - Sichuan Academy of Medical Sciences-Sichuan Provincial People'S Hospital
Chengdu, Sichuan, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 May 2023
- Primary completion
- 2 Aug 2025
- Completion
- 1 Sept 2025
- Last update posted
- 6 Jun 2023
- Registered enrollment
- 388
- Registry id
- NCT05869240
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.